High level of glycated hemoglobin (HbA1c) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus
Open Access
- 12 February 2021
- journal article
- research article
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 23 (6) , 504-513
Abstract
Повышенный уровень гликированного гемоглобина (HbA 1c ) у больных с COVID-19 является маркером тяжести течения инфекции, но не индикатором предшествующего сахарного диабетаKeywords
This publication has 27 references indexed in Scilit:
- Diabetes mellitus in the Russian Federation: Arguments and factsTerapevticheskii arkhiv, 2016
- Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With DiabetesMedicine, 2015
- Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2012
- Drugs affecting HbA1c levelsIndian Journal of Endocrinology and Metabolism, 2012
- Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*Critical Care Medicine, 2009
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 2009
- Elevated Admission Glucose and Mortality in Elderly Patients Hospitalized With Heart FailureCirculation, 2009
- Utility of HbA1c Levels for Diabetes Case Finding in Hospitalized Patients With HyperglycemiaDiabetes Care, 2003
- Feasibility and advantages of normothermia in patients with acute cerebral damage: preliminary results of a prospective randomised studyCritical Care, 2001
- Increased glycosylated haemoglobin A1 in opiate addicts: Evidence for a hyperglycaemic effect of morphineDiabetologia, 1982